Fatty acids (FAs) are known to impair insulin signaling in target cells. Accumulating evidences suggest that one of the major sites of FAs adverse effect is insulin receptor (IR). However, the underlying mechanism is yet unclear. An important clue was indicated in leptin receptor deficient (db/db) diabetic mice where increased circulatory FAs was coincided with phosphorylated PKCε and reduced IR expression. We report here that central to this mechanism is the phosphorylation of PKCε by FAs. Kinase dead mutant of PKCε did not augment FA induced IRβ downregulation indicating phosphorylation of PKCε is crucial for FA induced IRβ reduction. Investigation with insulin target cells showed that kinase independent phosphorylation of PKCε by FA occurred through palmitoylation. Mutation at cysteine 276 and 474 residues in PKCε suppressed this process indicating participation of these two residues in palmitoylation. Phosphorylation of PKCε endowed it the ability to migrate to the nuclear region of insulin target cells. It was intriguing to search about how translocation of phosphorylated PKCε occurred without having canonical nuclear localization signal (NLS). We found that F-actin recognized phospho-form of PKCε and chaperoned it to the nuclear region where it interact with HMGA1 and Sp1, the transcription regulator of IR and HMGA1 gene respectively and impaired HMGA1 function. This resulted in the attenuation of HMGA1 driven IR transcription that compromised insulin signaling and sensitivity.
Introduction
Interaction of insulin with its receptor tyrosine kinase triggers intracellular cascade of kinases that leads to cellular uptake of glucose in insulin target cells. Several authors have demonstrated that downregulation of IR is accompanied by diminished insulin signaling causing insulin resistance [1] [2] [3] [4] . A few significant information relevant to this are enumerated below (a) IR knockout in mice liver leads to the development of insulin resistance and type 2 diabetes [3] , (b) induction of endoplasmic reticulum stress abrogates IR expression that causes insulin resistance [5] , (c) number of IR per adipocyte significantly decreases in the obese patients [1] , (d) this has been further confirmed with fibroblasts, the precursor cells of adipocytes, collected from insulin resistant patients showed both quantitative and qualitative defects of IR [6] , (e) defects in IR gene expression have been detected in insulin resistant patients [7] . (f) HMGA1, architectural transcription factor of IR gene, has been found to be deficient in diabetic patients and this effected reduced IR expression [8] . Hence, from all these reports it appears that reduction of IR is associated with insulin signaling defect which produces insulin resistance and diabetic in human being.
To search the cause for such reduction, many suggested lipid as the major player. Reduced IR expression has been observed in mice with abdominal obesity and hepatic steatosis [9] . Saturated long chain FAs are shown to be associated with the defects of insulin signaling. Palmitate decreased IR protein and mRNA expression in hepatocyte and skeletal muscle cell lines that attenuates insulin signaling [4, 10] and a concentration dependent decline of IR occurs in insulin target cells due to palmitate [11] . Lipid transfection to skeletal muscle cells and adipocytes reduces IR expression that impairs insulin responsiveness [12] . These information are consistent in implying that FA induced reduction of IR is one of the causes to develop insulin resistance but how lipid is related to IR downregulation in insulin target cells is still unclear.
A few reports indicated interplay of protein kinase Cε (PKCε) in mediating the lipid induced IR damage. It has been shown that IR expression is inversely correlated to PKCε in diabetic obese rats [13] . Moreover, lipid induced hepatic insulin resistance could be prevented by knocking down of PKCε [14] . PKCε is implicated in the impairment of HMGA1 that coincided with the reduced IR expression [15] . These fragmented reports appear to be meaningful and there might be an Biochimica et Biophysica Acta 1812 (2011 [495] [496] [497] [498] [499] [500] [501] [502] [503] [504] [505] [506] association between lipid and PKCε which imposes defects in IR. Here we report that lipid induced phosphorylation of PKCε occurs due to palmitoylation. Phosphorylated PKCε is transported to the nuclear region by F-actin where it impaired HMGA1 resulting reduced IR expression that significantly decreases insulin sensitivity in target cells.
Materials and methods

Materials
All tissue culture materials were obtained from Gibco-BRL, Life Technologies Inc., Gaithersburg, USA. Anti-PKCε (anti-rabbit), antipPKCε (Ser-729, anti-rabbit), anti-HMGA1 (anti-rabbit), anti-pIRβ (Tyr 1150/1151, anti-mouse), anti-IRβ (anti-rabbit), anti-p-c-Jun (Ser-63/73, anti-rabbit) and anti-p-c-Fos (Thr-232, anti-rabbit) antibodies were purchased from Santa Cruz Biotechnology Inc., California, USA. Anti-F-actin (anti-mouse) and anti-pSp1 (Thr-453, anti-rabbit) antibodies were from Abcam Inc., Cambridge, USA. All fluorescent (goat anti-rabbit fluorescence iso-thiocyanate (FITC); rabbit anti-mouse rhodamine) and alkaline phosphatase conjugated secondary antibodies were purchased from Sigma Chemical Co., St. were purchased from GE Healthcare Biosciences Ltd., Kowloon, Hong Kong. All fatty acids, cerulenin, triacsin C and cytochalasin B were from Sigma Chemical Co., St. Louis MO, USA. PKCε translocation inhibitor peptide EAVSLKPT (εV1) was purchased from Calbiochem, Darmstadt, Germany. All the restriction enzymes and Gaussia Luciferase assay kit were from New England Biolabs (UK) Ltd. Hertfordshire, England, UK. Serum glucose level was measured by using glucose oxidase method and serum FFA levels were measured by acyl-CoA synthase and acyl-CoA oxidase methods (Roche Diagnostics, Indianapolis, USA). The other chemicals and reagents used were purchased from Sigma Chemical Co., St. Louis MO, USA.
Mice
Diabetic male db/db mice (BKS.Cg-m +/+ Lepr db /J, stock # 000642) and their age matched non-diabetic mice (C57BLKS/6J) obtained from Jackson's laboratory were housed in group of 5 individuals/cage under 12 h light/dark cycle at 23 ± 2°C (humidity 55 ± 5%) with ad libitum access to food and water. All experiments were performed following the guidelines prescribed by the Animal Ethics Committee.
FFA treatments
FFAs were conjugated with FFA-free bovine serum albumin following the method described by Chavez et al. [16] . Briefly, FFAs were dissolved in ethanol and diluted 1:100 in 1% FBS-DMEM containing 5% (w/v) bovine serum albumin.
Cell culture and treatments
The rat L6 skeletal muscle, human HepG2 and mouse 3T3-L1 cell lines were kind gifts from Dr. Partha P. Banerjee, Georgetown University Medical Center, Washington, DC, USA. Cells were cultured in a similar manner as described by us previously [15] . Briefly, L6 skeletal muscle cells were cultured in DMEM medium supplemented with 10% fetal calf serum, 25 mM glucose, 1% penicillin-streptomycin (Invitrogen) in a humidified 95% O 2 /5% CO 2 atmosphere at 37°C. Cells attaining 60-70% confluence were differentiated in DMEM containing 2% fetal bovine serum and 1% pen-strep for 4-6 days prior to all experiments. HepG2 and 3T3-L1 adipocytes were cultured in a similar manner as described previously [17] . Cells were incubated for 6 h with 0.3 mM concentration of different fatty acids conjugated with 5% BSA with or without inhibitors mentioned at specific places. PKCε siRNA, wild type and mutated pCMV-PKCε vectors were transfected to L6 myotubes (2 × 10 5 cell/well) by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) following manufacturer's protocol. After 48 h of transfection, cells were washed with DMEM. Transfected cells were then used for different experiments. On termination of incubations, cells were washed twice with ice-cold PBS and harvested with trypsin (0.25%)-EDTA (0.5 mM). Cell pellets were resuspended in lysis buffer (1% NP-40, 20 mM HEPES (pH 7.4), 2 mM EDTA, 100 mM NaF, 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 1 μg/ml pepstatin and 1 mM PMSF), sonicated on ice and lysates were centrifuged for 10 min at 10,000 g and protein concentrations of supernatant were determined by the method of Lowry et al. [18] .
Electrophoresis and immunoblotting
Sixty micrograms of protein from the lysates of control and treated cells were resolved on 10% or 12.5% SDS-PAGE and transferred to PVDF membranes (Millipore, Bedford, MA) with the help of Semi-Dry trans blot Apparatus (Bio-Rad Trans-Blot® SD-Cell). The membranes were first incubated with respective primary antibodies at 1:1000 dilutions followed by incubation with either alkaline phosphatase conjugated goat anti-rabbit or rabbit anti-mouse secondary antibodies at same dilutions using SNAP i.d.
TM Apparatus (Millipore, Bedford, MA). The protein bands were detected by using 5-bromro 4-chloro 3-indolyl phosphate/nitroblue tetrazolium (BCIP/NBT).
Reverse transcription-PCR (RT-PCR) and real time quantitative PCR (qPCR)
Total RNA was extracted from different incubations using TRI Reagent (Sigma-Aldrich) according to the manufacturer's instructions. RT-PCR was performed using Revert Aid ΤΜ first strand cDNA synthesis kit (Fermentas Life Sciences, Hanover, MD). Gene expression was quantified using Real time PCR (Applied Biosystems Inc. CA). PCR was performed using gene-specific primers with the following reaction conditions: initial activation step at 95°C for 15 min, then 40 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 30 s and final extension at 72°C for 30 s. Gapdh was simultaneously amplified in separate reactions. The C t value was corrected using corresponding Gapdh controls. Primer sequences used were as shown in Table 1 . H] 2-DOG (0.4 nmol/ml) was added to each of the incubations 5 min before the termination of experiment. Cells were washed thrice with ice-cold KRP buffer in the presence of 0.3 mM phloretin to correct the glucose uptake data from simple diffusion and non-specific trapping of radioactivity. Cells were harvested with trypsin (0.25%)-EDTA (0.5 mM), solubilized with 1% NP-40 and 2-DOG uptake was measured in a Liquid Scintillation counter (Perkin Elmer, Tri-Carb 2800TR).
Metabolic labeling
L6 skeletal muscle cells were incubated with 0.8 mCi/ml [ 14 C]-palmitic acid for varied time periods at 37°C and on termination of incubations cells were washed with PBS to remove the free label. PKCε was immunoprecipitated and subjected to electrophoresis followed by fluorography. We used CSS-palm palmitoylation algorithm [20] to predict the cysteine residues within the entire coding sequence of PKCε as probable site of palmitoylation and it was set to the highest cutoff in CSS-palm algorithms.
Co-immunoprecipitation
Cells were incubated without or with palmitate or palmitate plus εV1. On termination of incubation, nuclear fractions were extracted [19] and used for immunoprecipitation. Briefly, 200 μg of nuclear protein was incubated overnight at 4°C with either 2 μg of anti-Factin or anti-HMGA1 antibody. Around 50 μl of Protein A Sepharose was then added to each tube and incubated at 4°C for 2 h followed by centrifugation at 10,000g. Immunocomplexed F-actin or HMGA1 was resuspended in 500 μl of 0.1% CHAPS in PBS and washed thoroughly in PBS. Immunoprecipitates were boiled in 5× SDS sample buffer and resolved in 10% SDS-PAGE followed by immunoblotting with either anti-PKCε or anti-pPKCε antibody.
Confocal microscopy
Confocal microscopy was performed by following the description reported previously by us [21] . Briefly, control and treated L6 skeletal muscle cells were incubated with both anti-rabbit pPKCε and antimouse F-actin antibodies for 2 h followed by double staining with FITC-conjugated goat anti-rabbit and Rhodamine conjugated rabbit anti-mouse antibodies for 1 h. Coverslips were then mounted on glass slides and examined under laser scanning confocal microscope (Leica Corp., Rockleigh, NJ).
Immunoaffinity chromatography
To prepare pPKCε rich fraction, L6 skeletal muscle cells were incubated for 6 h with palmitate. On termination of incubation, cells were lysed and supernatant was isolated. The supernatant was passed through Microcon YM-50 followed by YM-100 filter devices to remove the protein below and above of 50 kDa and 100 kDa respectively. Filtrate from YM-100 was used for immunoaffinity chromatography where cyanogen bromide (CNBr) activated Sepharose 4B beads were conjugated with the anti-pPKCε antibody by following the procedure previously described by us [19] . Purified pPKCε was used for Surface plasmon resonance analysis.
Surface Plasmon Resonance (BIAcore) Study
To observe the interaction between pPKCε and HMGA1, Surface plasmon resonance experiments were performed on a BIAcore™ 3000 instrument (BIAcore, Inc., Uppsala, Sweden) using NTA sensor chip following manufacturer's instructions. Briefly the NTA sensor chip was equilibrated with running buffer containing 10 mM HEPES (pH 7.5), 150 mM NaCl, 0.005% Surfactant P20, 50 mM EDTA followed by priming the chip with 0.1 M NiCl 2 and again equilibrated with running buffer, then pure His-HMGA1 protein flowed over the Ni 2+ coated NTA sensor chip surface at a flow rate of 5 μl/min. The final amount of His-HMGA1 protein covalently immobilized on the surface was 600RU. To observe the pattern of HMGA1-pPKCε binding, pPKCε from 50 to 400 nM concentrations was run over the HMGA1 immobilized Ni 2+ primed NTA chip at a flow rate of 5 μl/min for 10 min. Binding between these two proteins was monitored in real time via the changes in refractive index which was proportional to the changes in mass concentration at the sensor chip surface and plotted as Resonance Unit (RU) versus time.
The sensorgram was corrected by subtracting the initial level of SPR signal before injection of the pPKCε. Binding kinetics was analyzed for one-to-one Langmuir binding model provided with BIA evaluation software.
Immunocomplex kinase assays
L6 skeletal muscle cells were incubated with palmitate in presence of [γ 32 p]-ATP and on termination of incubation, cytosolic fractions were isolated and subjected to Microcon filter devices (Millipore, Bedford, MA) through YM-50 and then YM-100, filtrate from YM-100 was collected and subjected to immunoprecipitation with anti-pPKCε antibody. SDS sample buffer and resolved on 10% SDS-PAGE, transferred to PVDF membrane, followed by autoradiography. Radioactive spot corresponding to HMGA1 or Sp1 was cut from the PVDF membrane and radioactivity was measured in a liquid scintillation counter.
Chromatin Immunoprecipitation (ChIP) assay
ChIP assay was performed using a ChIP assay kit (Upstate, Temecula, CA) according to the manufacturer's protocol using anti-HMGA1 antibody. The primers (forward: 5′-AACCACCTCGAGTCACCAAAA-3′ and reverse: 5′-AGAGAGAGGGAAAGCTTGCAG-3′) were used to amplify the immunoprecipitated insulin receptor promoter sequence. The PCR products were resolved on ethidium bromide stained 1.5% agarose gel and image was captured by Bio-Rad Gel documentation system.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from control, palmitate, and palmitate plus εV1 treated cells as described previously [22] . EMSA was performed by using nuclear extracts prepared from different incubations using oligonucleotide probes specific for Sp1 binding site (forward: 5′-ATTTGCATGGCCCCGCCCCCTGAGT-3′, reverse: 5′-ACT-CAGGGGGCGGGGCCATGCAAAT-3′) within the HMGA1 promoter. The probes were end labeled with [γ 32 P]-ATP with T4 polynucleotide kinase and incubated with 10 μg of nuclear extracts in 20 μl of binding reaction for 45 min on ice. For supershift assay, 2 μg of anti-Sp1 antibody was added to the nuclear extract and the reaction mixture was resolved on 5% polyacrylamide gel and visualized by Phosphorimager (GE Healthcare, USA).
Site directed mutagenesis
A pCMV6-PKCε construct containing 5537 bp of human protein kinase C, epsilon gene (Genbank/EMBL NM_005400.2) was purchased from OriGene Technologies, Inc, Rockville, MD, USA. This vector construct was used as template for the generation of mutant plasmids with the help of QuikChange site-directed mutagenesis system (Stratagene, CA, USA). For mutated PKCε plasmid construction, sense oligos included oligohPKCεS729A (5′-GAGGAATT-CAAAGGTTTCGCCTACTTTGGTGAAGACC-3′), oligohPKCεΔ729 (5′-GGAGGAATTCAAAGGTTTCTACTTTGGTGAAGACCTGA-3′) oligohPK-CεC13A (5′-GGCCTTCTTAAGATCAAAATCGCCGAGGCCGTGAGCT-3′), oligohPKCεC276A (5′-AGGGTTTGCAGTGTAAAGTCGCCAAA-ATGAATGTTCACCGTC-3′), oligohPKCεC474A (5′-ACCTTACCCAACTC-TACGCCTGCTTCCAGACCAAGG-3′), oligohPKCεC652A (5′-CAAGCGCCTGGGCGCTGTGGCATCGCAG-3′).
Plasmid construct, transfection and reporter assay
IRP-GLuc plasmid was generated by following a previously described method with some modifications [23] . Briefly, the insulin receptor promoter sequence was amplified by PCR taking phINSRP-1 as a template with forward (5′-GGGGGAATTCGGCCATTGCACTCCA-3′) and reverse (5′-AATTGGATCCTGCGGGAGCGCGGGG-3′) primers. The PCR products were digested with EcoRI/BamHI and cloned into the pGLuc vector yielding pIRP-GLuc. The sequence of cloned promoter region was confirmed by sequencing. Cells were transfected for 72 h with pIRPGLuc plasmid (0.25 mg/well) using Lipofectamine TM 2000 and luciferase activity was measured from the media of incubated cells.
Statistical analysis
All data were derived from at least three independent experiments and analyzed by one-way analysis of variance (ANOVA); where the F value indicated significance, means were compared by a post hoc multiple range test. All values were means ± SEM.
Results
Correlation between fatty acid, PKCε phosphorylation and downregulation of IR
To study the lipid's association in IR degradation, we selected genetically modified leptin receptor deficient db/db mice which are extremely insulin resistant and obese in comparison to their control littermates (Fig. 1A, B) . There was a drastic reduction of IRβ protein and gene expression in insulin target tissues of db/db mice as compared to their control (Fig. 1C) . This was coincided with significant increase in circulatory FFA level, where palmitate and myristate were prevalent (Fig. 1D, E) . Interestingly, there was a significant amount of phosphorylated PKCε (pPKCε) in insulin target tissues of db/db mice as compared to their control, while its nonphospho form did not show such difference (Fig. 1F) . Nutritionally induced high fat diet (HFD) rats also exhibited similar trend (Fig.  S1A) . These results from in vivo mice model provided two valuable information -(i) two long chain FAs are important in producing damage and (ii) association of phospho-PKCε with IRβ reduction. These findings prompted us to examine the effect of saturated and unsaturated FAs on the reduction of IRβ in L6 myotubes. Maximum reduction occurred with two long chain saturated fatty acids, palmitate and myristate ( Fig. 2A) . These FAs greatly increased PKCε phosphorylation with concurrent reduction of IRβ expression in insulin target cells (Fig. 2B, C) . This emphasizes the involvement of pPKCε with IRβ downregulation. It could be seen from Fig. 2D that an unsaturated fatty acid, oleate, also phosphorylated PKCε although with the same concentration it showed no effect on IR expression ( Fig. 2A) (Fig. 2E) .
It was evident that higher concentration of palmitate may cause cellular apoptosis [24, 25] , however, varied concentrations of palmitate conjugated with BSA demonstrated that exposure till 0.4 mM had no effect on caspase 3 activity, a marker of apoptosis, in L6 myotube whereas 0.5 mM showed a marginal effect (Fig. 2F) . We therefore selected 0.3 mM concentration of palmitate conjugated BSA in our experiments as it will have no apoptotic effect during incubation periods (Fig. S1B) .
IRβ degradation by FAs is executed through pPKCε
We, therefore, felt it to be necessary to study whether pPKCε is mediating palmitate effect on downregulation of IRβ expression. To investigate this, PKCε was mutated or deleted at serine 729 phosphorylation site and transfected to L6 myotubes. Incubation of these transfected cells with palmitate did not increased pPKCε or inhibited IRβ expression (Fig. 3A) . Forced expression of PKCε in L6 myotubes followed by palmitate incubation markedly reduced IRβ expression, even less than palmitate lone effect while in PKCε knockout (KO) cells palmitate failed to reduce IRβ expression. These results strongly indicate that population of pPKCε could be related to the magnitude of IRβ reduction (Fig. 3B) . We then examined palmitate effect on downstream insulin signaling molecules and found that palmitate also inhibited insulin stimulated activation of IRS1 and Akt along with the IRβ (Fig. 3C ). Taken together, palmitate induced phosphorylation of PKCε appears to be a key step in FA induced IRβ degradation which resulted impairment of downstream signaling molecules.
Lipid induced phosphorylation of PKCε is due to palmitoylation
Cellular phosphorylation of PKC is always dependent on PDK1; in contrast, FA induced phosphorylation appears to be not through PDK1 [15, 26] . Myristoylated PKCε has been shown to be constitutively phosphorylated in PDK1 knock out cells [26] . Here we show that radiolabeled palmitate incubation of L6 myotubes effected palmitoylation of PKCε (Fig. 4A) . Addition of HCl, NaOH or hydroxylamine inhibited the palmitoylation indicating presence of thioester bond between radiolabeled palmitate and PKCε (Fig. 4B) . That palmitoylation of PKCε leads to its phosphorylation was evident from the effect of palmitoylation inhibitors, triacsin C and cerulenin, which suppressed palmitoylation and subsequently inhibited phosphorylation of PKCε (Fig. 4C, S1C) . To search the possible site(s) of palmitoylation on PKCε, we mutated four probable cysteine residues in PKCε i.e., 13, 276, 474 and 652 (Fig. 4D) and transfected them to L6 myotubes followed by incubation with [ 14 C]-palmitate. Determination of palmitoylated PKCε through immunoprecipitation followed by fluorography and immunoblot for pPKCε suggests that mutation at 276 and 474 cysteine residues completely abolished both palmitoylation and phosphorylation whereas mutation at 13 and 652 had no effect (Fig. 4E) . Hence, 276 and 474 cysteine residues are the sites for palmitoylation which leads to PKCε phosphorylation.
pPKCε translocation to nuclear region is chaperoned by F-actin
Previously, we have observed that phosphorylation of PKCε has endowed it the ability for nuclear translocation [15] but could not understand how it occurs in the absence of canonical nuclear localization signal (NLS). From some earlier information it occurred that F-actin, which has 13 NLS, may be a transporter of pPKCε since phorbol ester induced activated PKCε remains bound to F-actin [27, 28] and they could be detected as co-localized in the nuclear region [29] . Coimmunoprecipitation study indicates that in palmitate and myristate incubated L6 myotubes, F-actin formed a complex with pPKCε but not with its non-phospho form (Fig. 5A ). This was also observed with 3T3-L1 adipocytes (Fig. S1D) . F-actin destabilizing agent, Cytochalasin B (cytoB) and PKCε translocation inhibitor, εV1 blocked PKCε translocation to nuclear region (Fig. 5B) . Confocal microscopy study exhibited weak and diffused staining of pPKCε in the cytoplasm of control cells and a total absence of it in the nuclear region, while in palmitate incubated cells a considerable amount of pPKCε was detected in the nuclear region and found to be colocalized with F-actin (Fig. 5C) . These results provided an additional support to the above contention that only phospho-form of pPKCε is chaperoned to nuclear region by Factin in palmitate incubated cells.
pPKCε entry into the nuclear region effected HMGA1 impairment
Biological relevance of pPKCε translocation to nuclear region of insulin target cells was previously indicated by demonstrating its association with HMGA1 [15] . HMGA1 is a transcriptional regulator of IR gene [8, 30, 31] . Here we show that pPKCε form a complex with HMGA1 in the nuclear extract of palmitate incubated cells which was inhibited by cytochalasin B and εV1 (Fig. 6A) . To assess the binding affinity between pPKCε and HMGA1, we used surface plasmon resonance analysis (SPR, BIAcore). Pure His-HMGA1 was tethered to a Ni 2+ -NTA sensor chip via their NH 2 terminal His 6 moieties and pPKCε was flowed over the sensor surface with various concentrations (50-400 nM). The K D value was found to be 10 nM indicating a high affinity binding between pPKCε and HMGA1 (Fig. 6B) . Immunoblot of palmitate incubated cells demonstrated a shift of HMGA1 protein band along with its weak expression which implied HMGA1 phosphorylation and reduction respectively (Fig. 6C) . Suppression of HMGA1 gene expression was also witnessed by RT-PCR and its prevention by cerulenin or triacsin C imply interplay of pPKCε. (Fig. 6C) . Phosphorylation of HMGA1 by pPKCε was detected by the transfer of radiolabeled phosphate in cell free incubation indicating that HMGA1 is a substrate of activated PKCε (Fig. 6D) . In searching the basis of reduced HMGA1 expression we found increased phosphorylation of Sp1 but not in Jun and Fos (Fig. 7A ) which was again indicated by the transfer of radiolabeled phosphate from 32 pPKCε to Sp1 (Fig. 7B) . Sp1 binding to HMGA1 promoter was significantly reduced in palmitate incubated cells, while it was prevented in cells pretreated with εV1. Addition of anti-Sp1 antibody supershifted the binding complex indicating that this band was constituted by Sp1 (Fig. 7C) . These results suggest that the phosphorylation of Sp1 by pPKCε inhibits its binding to HMGA1 promoter resulting reduction of its gene expression. There are evidences that phosphorylation of Sp1 deactivates it and decrease it's binding to DNA. Results described so far indicate that pPKCε is a key player in FA induced damage of insulin signaling.
Defects in HMGA1 due to pPKCε abrogate IRβ expression
Since F-actin-pPKCε complex has greater ability for phosphotransferase activity [27] , it is expected both HMGA1 and Sp1 phosphorylation would take place more efficiently and that would produce defects in HMGA1. To examine this, we performed chromatin immunoprecipitation (ChIP) assay and observed a reduction of HMGA1 binding to IRβ promoter in palmitate treated cells. This was prevented by cerulenin, triacsin C, cytochalasin B and εV1 indicating that phosphorylation followed by nuclear translocation of pPKCε is involved in inhibiting HMGA1 binding to IRβ promoter (Fig. 8A) . . Palmitate induced pPKCε nuclear translocation is mediated through F-actin. (A) Nuclear extract isolated from palmitate (P) or myristate (M) incubated L6 myotubes were subjected to immunoprecipitation with anti-F-actin antibody followed by probing with pPKCε or PKCε antibodies. β actin was used as internal control. (B) L6 myotubes were incubated without or with palmitate in the presence or absence of εV1 or Cytochalasin B (CytoB). On termination of incubations cytosolic (Cyt) and nuclear (Nu) fractions were prepared and subjected to immunoblot analysis with pPKCε antibody, β actin was used as internal control. (C) L6 myotubes were incubated without (control) or with palmitate, on termination of incubations, cells were fixed and permeabilized. Permeabilized cells were coincubated with anti-rabbit pPKCε and anti-mouse F-actin antibodies for 4 h followed by FITC and Rhodamine conjugated respective secondary antibodies for 2 h. DAPI was used to stain the nucleus. Transfection of pIRP-Gluc plasmid in L6 myotubes followed by IRβ reporter assay demonstrated a significant decrease in luciferase activity due to palmitate incubation. Attenuation of IRβ promoter activity could also be prevented by cerulenin, triacsin C, cytoB and εV1, suggesting once again the association of pPKCε in decreasing IRβ promoter activity (Fig. 8B ). All these suggest a deleterious effect of pPKCε on IRβ expression.
pPKCε mediated IRβ downregulation impairs insulin sensitivity
To examine whether palmitate-pPKCε-HMGA1 mediated reduction of IRβ expression could reduce insulin sensitivity, we investigated GFPGlut4 migration to cell membrane and [ 3 H]-2DOG uptake by L6 myotubes as these two are important markers for insulin action. In GFP-Glut4 plasmid transfected L6 myotubes, insulin effected Glut4 migration from cytosol to membrane was prevented by palmitate while in cells cotransfected with mutated PKCε vector, where serine 729 was replaced by alanine, palmitate did not inhibit insulin stimulated Glut4 migration (Fig. 9A) . This was further evident from [ 3 H]-2DOG uptake study in L6 myotubes (Fig. 9B ). These findings demonstrate that FA's damage to insulin sensitivity is mediated through PKCε.
Discussion
Binding of insulin to IR initiates insulin signaling in classical insulin target cells. Several authors have demonstrated an association between FAs and decreased IR in insulin target tissues and cells. These defects in IR impair insulin signaling that compromises insulin sensitivity and insulin resistance [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 15] . Such a large number of citations favoring the issue that deficiency of IR is related to insulin signaling defect raises a question about the spare receptor in target cells. Concept of spare receptor in insulin target cells does not hold good any more, insulin occupation of all high affinity receptor binding sites is required to ensure full receptor kinase activation thus void the possibility of spare receptor in skeletal muscle [32, 33] and hepatocytes [34] . Since one high affinity IR is for one molecule of insulin [35] , detection of absence of spare receptor is meaningful. Evidences available with adipocytes suggest that spare receptor phenomenon is due to post receptor event [32, 36] . The reason for CNBr activated sepharose 4B column. 32 pPKCε was incubated with HMGA1 protein for 30 min at 37°C in cell free condition, HMGA1 was pulled down with anti-HMGA1 antibody followed by SDS-PAGE and autoradiographed. PVDF membrane corresponding to the radioactive spots was cut and radiolabeled phosphate incorporated into HMGA1 was measured in a liquid scintillation counter. Data were means ± SEM of three individual observations, *p b 0.001; vs HMGA1.
this discussion is to emphasize the biological relevance of large number of above mentioned reports which demonstrated association of FA with IR reduction and found that this deficiency leads to insulin signaling defects which affects insulin sensitivity [4, [10] [11] [12] [13] 15] . We have observed that in obese type 2 diabetic db/db mice about 85-90% of IRβ has been degraded in skeletal muscle with almost equal amount of reduction in its gene expression and this has strikingly reduced insulin sensitivity. Hence, FA induced degradation of IR would likely implement insulin resistance, a hall mark of type 2 diabetes. pPKCε prepared according to the above description was incubated for 30 min at 30°C with Sp1 followed by subjected to autoradiography. PVDF membrane corresponding to the radioactive spot was cut and incorporation of radiolabeled phosphate to Sp1 was measured in a liquid scintillation counter. Data represents means ± SEM of three individual experiments, *p b 0.01 vs Sp1. (C) Nuclear extracts isolated from control, palmitate or palmitate plus εV1 incubated L6 myotubes were subjected to electrophoretic mobility shift assay (EMSA). Probing with anti-Sp1 antibody showed a shift of the band which indicates specific binding of Sp1 on the HMGA1 promoter. Fig. 8 . pPKCε induced defects on HMGA1 attenuates IRβ promoter activity. (A) L6 myotubes were incubated without or with palmitate in the presence of cerulenin or triacsin C or CytoB or εV1. On termination of the incubations, chromatin immunoprecipitation assay (ChIP) was performed with cell lysate by immunoprecipitating HMGA1 bound IR promoter region using anti-HMGA1 antibody. The recovered DNA was used as a template for PCR analysis with primers of IRβ promoter. (B) IR promoter (pIRP-GLuc) driven luciferaseexpressing plasmid was transfected into L6 myotubes followed by the same regime of incubation as indicated above. On termination of incubation, luciferase activity was measured in a luminometer. Data represents means ± SEM of five individual experiments, *p b 0.001 vs C, #p b 0.01 vs P.
Loss of insulin sensitivity due to FA induced defects in IR signaling pathway is known for a long time. There are reports on the disruption of every molecules of insulin signaling pathway due to FAs [37] [38] [39] . However, defects of any of them would adversely affect insulin sensitivity. This makes our understanding a little cloudy although there is no confusion that it is FAs which produces this defect as drug induced decrease of circulatory FAs improves insulin sensitivity [40] . About a decade ago Ikeda et al. [13] , taking a well characterized diabetic animal model i.e., sand rat (Psammomys obesus) demonstrated that PKCε overexpression and activation has a link with decreased IR expression and that impaired insulin downstream signaling. In fact, there are several reports on PKCε involvement in insulin resistance and type 2 diabetes [4, 14, 41] on one hand and loss of insulin sensitivity due to FA induced IR degradation on the other [4, 10, 11] but a link between them remains unclear. Present investigation has contributed to make this understanding clear. We have shown that target of FAs is PKCε, it begins disruption of insulin signals by phosphorylating PKCε in a PDK1 independent pathway. Saturated fatty acids, palmitate and myristate phosphorylated PKCε, an unsaturated fatty acid, oleate also exhibited this property but it has no inhibitory effect on IR expression. However, oleate adverse effect on insulin sensitivity could be due to serine/threonine phosphorylation of IRS1 as reported by Ragheb et al. [42] . Once phosphorylated, pPKCε moves to the nuclear region. It was surprising to detect it there as PKCε lacks NLS. We then understand the purpose of FA induced phosphorylation of PKCε and why it is localized in the nuclear region as a complex with F-actin. F-actin which has 13 NLS and it recognizes only phospho-form of PKCε because phosphorylation exposes hexapeptide F-actin binding motif at regulatory domain of PKCε. This permits F-actin binding and transport of pPKCε to the nuclear region [27, 29] . In the nuclear region, pPKCε plays a key role, it phosphorylates HMGA1 and downregulates its expression by deactivating its transcription factor Sp1. Phosphorylation of HMGA1 by PKCs has been amply reported earlier and this restricted its mobility [43, 44] . Phosphorylated HMGA1 preferentially interacts with positively charged histone that effected increase of its residence time in heterochromatin region [45] . Regulation of HMGA1 expression is dependent on the cooperation between Sp1 and AP1 transcription factors [46] and phosphorylation of Sp1 has been shown to inhibit its DNA binding activity [47] . These together attenuated IR gene and protein expression which seriously compromised insulin sensitivity. Novelty of our work lies in deciphering the underlying mechanism on FA induced IRβ downregulation, the central regulator is phospho-PKCε which forms connection between them and disrupt insulin signaling by impairing HMGA1. We have demonstrated that through this pathway FA caused insulin resistance in classical target cells.
Supplementary materials related to this article can be found online at doi:10.1016/j.bbadis.2011.01.001. 
